国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Rhodobacter capsulatus Trans-acting regulatory protein hvrA (hvrA) CSB-YP331553RLC
CSB-EP331553RLC
CSB-BP331553RLC
CSB-MP331553RLC
CSB-EP331553RLC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter capsulatus Photosynthetic apparatus regulatory protein regA (regA) CSB-YP331554RLC
CSB-EP331554RLC
CSB-BP331554RLC
CSB-MP331554RLC
CSB-EP331554RLC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Canavalia lineata Leghemoglobin CSB-YP331555CCC
CSB-EP331555CCC
CSB-BP331555CCC
CSB-MP331555CCC
CSB-EP331555CCC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Uncharacterized protein PA4219 (PA4219), partial CSB-YP331556EZX
CSB-EP331556EZX
CSB-BP331556EZX
CSB-MP331556EZX
CSB-EP331556EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter agglomerans Monofunctional chorismate mutase (aroQ) CSB-YP331557EKP
CSB-EP331557EKP
CSB-BP331557EKP
CSB-MP331557EKP
CSB-EP331557EKP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Myosin IC heavy chain (myoC), partial CSB-YP331559DKK
CSB-EP331559DKK
CSB-BP331559DKK
CSB-MP331559DKK
CSB-EP331559DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum Uncharacterized protein Cgl1270/cg1434 (Cgl1270, cg1434), partial CSB-YP331560DWY1
CSB-EP331560DWY1
CSB-BP331560DWY1
CSB-MP331560DWY1
CSB-EP331560DWY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptomyces coelicolor Putative polyketide hydroxylase (SCO5321), partial CSB-YP331561FOB
CSB-EP331561FOB
CSB-BP331561FOB
CSB-MP331561FOB
CSB-EP331561FOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acholeplasma phage L2 Uncharacterized 66.6 kDa protein, partial CSB-YP331562ABJ1
CSB-EP331562ABJ1
CSB-BP331562ABJ1
CSB-MP331562ABJ1
CSB-EP331562ABJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acholeplasma phage L2 Uncharacterized 9.6 kDa protein CSB-YP331563ABJ
CSB-EP331563ABJ
CSB-BP331563ABJ
CSB-MP331563ABJ
CSB-EP331563ABJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acholeplasma phage L2 Uncharacterized 18.2 kDa protein CSB-YP331564ABJ
CSB-EP331564ABJ
CSB-BP331564ABJ
CSB-MP331564ABJ
CSB-EP331564ABJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acholeplasma phage L2 Probable integrase/recombinase CSB-YP331565ABJ
CSB-EP331565ABJ
CSB-BP331565ABJ
CSB-MP331565ABJ
CSB-EP331565ABJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acholeplasma phage L2 Uncharacterized 14.0 kDa protein CSB-YP331566ABJ
CSB-EP331566ABJ
CSB-BP331566ABJ
CSB-MP331566ABJ
CSB-EP331566ABJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acholeplasma phage L2 Uncharacterized 9.3 kDa protein CSB-YP331567ABJ
CSB-EP331567ABJ
CSB-BP331567ABJ
CSB-MP331567ABJ
CSB-EP331567ABJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acholeplasma phage L2 Uncharacterized 25.6 kDa protein CSB-YP331568ABJ
CSB-EP331568ABJ
CSB-BP331568ABJ
CSB-MP331568ABJ
CSB-EP331568ABJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acholeplasma phage L2 Uncharacterized 81.3 kDa protein, partial CSB-YP331569ABJ1
CSB-EP331569ABJ1
CSB-BP331569ABJ1
CSB-MP331569ABJ1
CSB-EP331569ABJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acholeplasma phage L2 Uncharacterized 26.1 kDa protein CSB-YP331570ABJ
CSB-EP331570ABJ
CSB-BP331570ABJ
CSB-MP331570ABJ
CSB-EP331570ABJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Spinacia oleracea DNA-binding protein S1FA (S1FA) CSB-YP331571FKI
CSB-EP331571FKI
CSB-BP331571FKI
CSB-MP331571FKI
CSB-EP331571FKI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zea mays DNA-binding protein S1FA (S1FA) CSB-YP331572ZAX
CSB-EP331572ZAX
CSB-BP331572ZAX
CSB-MP331572ZAX
CSB-EP331572ZAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mytilus edulis FMRFamide-like neuropeptide ALAGDHFFRF-amide CSB-YP331573MWU
CSB-EP331573MWU
CSB-BP331573MWU
CSB-MP331573MWU
CSB-EP331573MWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>